Robert C. Murphy, B.Sc., Ph.D.
Robert Murphy received his PhD from the Massachusetts Institute of Technology under the tutelage of Klaus Biemann, followed by a post-doctoral fellowship at Harvard Medical School under the direction of Manfred Karnovsky. Dr. Murphy took a faculty position at the University of Colorado School of Medicine at Denver, receiving tenure in 1976 and being named a full Professor of Pharmacology in 1980. Dr. Murphy spent a sabbatical year with Bengt Samuelsson at the Karolinska Institute in Sweden where he carried out the structure elucidation of leukotriene C in 1978-79. He served as a Professor at the National Jewish Medical and Research Center, and was President of the American Society for Mass Spectrometry from 1990-1992. Dr. Murphy serves as the Director of the Glycerolipids Core as part of the LIPIDMAPS program. Among other awards, he received the 2005 Faculty Excellence in Teaching Award from the Department of Pharmacology, the 2007 Outstanding Achievement Award from the Eicosanoid Research Society and was appointed Distinguished Professor of the University of Colorado in 2008.
Research in the Murphy laboratory focuses on the basic biochemistry and pharmacological control of lipid mediators (including leukotrienes, PAF, metabolites of arachidonic acid, and oxidized phospholipids) derived from both enzymatic and nonenzymatic pathways. Dr. Murphy employs sophisticated mass spectrometry techniques for the qualitative and quantitative analysis of lipid mediators and mediator metabolites to address critical issues in biochemistry. He has published over 400 peer reviewed research articles and book chapters, and has a Web of Science h-index of 60.
Department of Pharmacology, MS 8303 University of Colorado Denver, Aurora, CO 80045, U.S.A.